| Risk of prostate cancer–specific mortality following biochemical recurrence after radical prostatectomy SJ Freedland, EB Humphreys, LA Mangold, M Eisenberger, FJ Dorey, ... Jama 294 (4), 433-439, 2005 | 1632 | 2005 |
| Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium AW Partin, LA Mangold, DM Lamm, PC Walsh, JI Epstein, JD Pearson Urology 58 (6), 843-848, 2001 | 1466 | 2001 |
| Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases … DV Makarov, BJ Trock, EB Humphreys, LA Mangold, PC Walsh, JI Epstein, ... Urology 69 (6), 1095-1101, 2007 | 651 | 2007 |
| Characteristics of insignificant clinical T1c prostate tumors: a contemporary analysis PJ Bastian, LA Mangold, JI Epstein, AW Partin Cancer 101 (9), 2001-2005, 2004 | 300 | 2004 |
| Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies AW Partin, L Van Neste, EA Klein, LS Marks, JR Gee, DA Troyer, ... The Journal of urology 192 (4), 1081-1087, 2014 | 257 | 2014 |
| Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy PJ Bastian, GS Palapattu, X Lin, S Yegnasubramanian, LA Mangold, ... Clinical cancer research 11 (11), 4037-4043, 2005 | 244 | 2005 |
| Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause … SJ Freedland, EB Humphreys, LA Mangold, M Eisenberger, FJ Dorey, ... Journal of Clinical Oncology 25 (13), 1765-1771, 2007 | 221 | 2007 |
| RETRACTED: EPCA-2: A Highly Specific Serum Marker for Prostate Cancer ES Leman, GW Cannon, BJ Trock, LJ Sokoll, DW Chan, L Mangold, ... Urology 69 (4), 714-720, 2007 | 200 | 2007 |
| Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer E Shrestha, JR White, SH Yu, I Kulac, O Ertunc, AM De Marzo, ... The Journal of urology 199 (1), 161-171, 2018 | 199 | 2018 |
| Radical prostatectomy for clinical stage T3a disease SJ Freedland, AW Partin, EB Humphreys, LA Mangold, PC Walsh Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 188 | 2007 |
| Proenzyme PSA for the early detection of prostate cancer in the 2.5–4.0 ng/ml total PSA range: preliminary analysis LJ Sokoll, DW Chan, SD Mikolajczyk, HG Rittenhouse, CL Evans, ... Urology 61 (2), 274-276, 2003 | 186 | 2003 |
| Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans SL Zheng, J Sun, Y Cheng, G Li, FC Hsu, Y Zhu, BL Chang, W Liu, ... Journal of the National Cancer Institute 99 (20), 1525-1533, 2007 | 152 | 2007 |
| Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10 PJ Bastian, ML Gonzalgo, WJ Aronson, MK Terris, CJ Kane, CL Amling, ... Cancer 107 (6), 1265-1272, 2006 | 152 | 2006 |
| Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality SJ Freedland, EB Humphreys, LA Mangold, M Eisenberger, AW Partin The Journal of urology 176 (4), 1404-1408, 2006 | 135 | 2006 |
| Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high‐risk cohort of men with negative initial prostate biopsies BJ Trock, MJ Brotzman, LA Mangold, JW Bigley, JI Epstein, D McLeod, ... BJU international 110 (1), 56-62, 2012 | 117 | 2012 |
| Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy M Müntener, JI Epstein, DJ Hernandez, ML Gonzalgo, L Mangold, ... European urology 53 (4), 767-776, 2008 | 116 | 2008 |
| Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy PJ Bastian, GS Palapattu, S Yegnasubramanian, X Lin, CG Rogers, ... Clinical cancer research 13 (18), 5361-5367, 2007 | 114 | 2007 |
| Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity K Bouwman, J Qiu, H Zhou, M Schotanus, LA Mangold, R Vogt, ... Proteomics 3 (11), 2200-2207, 2003 | 114 | 2003 |
| Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays DA Faith, WB Isaacs, JD Morgan, HL Fedor, JL Hicks, LA Mangold, ... The Prostate 61 (3), 215-227, 2004 | 111 | 2004 |
| Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer MA Khan, AW Partin, LA Mangold, JI Epstein, PC Walsh Urology 62 (5), 866-871, 2003 | 111 | 2003 |
